Treatment patterns in advanced/metastatic non-small-cell lung cancer in China: results from the CancerMPact ® survey 2021
Open Access
- 2 May 2024
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 20 (19) , 1319-1331
Abstract
Aim: To report the treatment patterns of advanced/metastatic non-small-cell lung cancer (NSCLC) in China from a physician survey (CancerMPact®). Materials & methods: A total of 206 Chinese physicia... Plain language summary The most common type of lung cancer is called non-small-cell lung cancer (NSCLC). When lung cancer spreads beyond the lung, it is called advanced. Doctors in China who treat ...Keywords
This publication has 17 references indexed in Scilit:
- Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020Cancer Treatment and Research Communications, 2021
- Research progress in immune checkpoint inhibitors for lung cancer in ChinaTherapeutic Advances in Medical Oncology, 2021
- Update 2020: Management of Non-Small Cell Lung CancerLung, 2020
- Epidemiology of lung cancer and lung cancer screening programs in China and the United StatesCancer Letters, 2020
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and TreatmentMayo Clinic Proceedings, 2019
- Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOSAnnals of Oncology, 2019
- Epidemiology of lung cancer in ChinaThoracic Cancer, 2018
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2018
- Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung CancerLung, 2018
- Lung cancer: current therapies and new targeted treatmentsThe Lancet, 2017